Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in Sweden and the UK: The Case of Risperidone
Berdud M, Wallin-Bernhardsson N, Zamora B, Lindgren P & Towse, A
Read more and download publication
OHE Research Paper
July 2019
Office of Health Economics, 2019
